Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04387461 |
|---|---|
| Brief Title: | Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin (CORE-001) |
| First Submitted : | May 5, 2020 |
| First Submitted that Met QC Criteria : | May 12, 2020 |
| First Posted : | May 13, 2020 |
| Last Update Submitted that Met QC Criteria : | August 22, 2022 |
| Last Update Posted : | August 24, 2022 |